EverSource Wealth Advisors’s Assembly Biosciences ASMB Stock Holding History

EverSource Wealth Advisors’s Portfolio ASMB Stock Details ASMB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.53K	Hold	55	–	–	﹤0.01%	3730
2025 Q4	$1.87K	Hold	55	–	–	﹤0.01%	3525
2025 Q3	$1.41K	Hold	55	–	–	﹤0.01%	3645
2025 Q2	$997	Hold	55	–	–	﹤0.01%	3740
2025 Q1	$526	Hold	55	–	–	﹤0.01%	3440
2024 Q4	$868	Hold	55	–	–	﹤0.01%	3015
2024 Q3	$833	Hold	55	–	–	﹤0.01%	2763
2024 Q2	$803	Hold	55	–	–	﹤0.01%	2782
2024 Q1	$686	Hold	55	–	–	﹤0.01%	2656
2023 Q4	$545	Buy	+55	New	+$523	﹤0.01%	2508

Other funds holding ASMB

Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

EverSource Wealth Advisors's ASMB Position: Q1 2026 in Review

EverSource Wealth Advisors held its Assembly Biosciences (ASMB) position steady in Q1 2026 at 55 shares worth $1.53K. The position accounts for ﹤0.01% of the portfolio, ranked #3730.

EverSource Wealth Advisors first reported a position in ASMB in Q4 2023 and has held it in 10 quarters since. The position peaked at $1.87K in Q4 2025. 75 funds tracked by Wall St. Rank hold ASMB as of Q1 2026.

EverSource Wealth Advisors held 55 shares of Assembly Biosciences worth $1.53K as of Q1 2026.
EverSource Wealth Advisors left its Assembly Biosciences share count unchanged in Q1 2026.
Assembly Biosciences made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q1 2026, its #3730 holding.
EverSource Wealth Advisors first reported a position in Assembly Biosciences in Q4 2023 and has held it in 10 quarters since.
EverSource Wealth Advisors's Assembly Biosciences position peaked at $1.87K in Q4 2025.
75 funds tracked by Wall St. Rank held Assembly Biosciences as of Q1 2026.

Based on EverSource Wealth Advisors's 13F filing for Q1 2026, filed 14 May 2026.